title: Osteoblastic healing response: discordant PET/CT findings.
authors: Department of Nuclear Medicine, AZ Alma Sijsele, Sijsele-Damme, Belgium. filip.gemmel@azalma.be
authors: Filip
authors: F
authors: Gemmel
authors: Silvia A
authors: SA
authors: Eshuis
authors: Femke
authors: F
authors: van Vollenhoven
authors: Paul
authors: P
authors: Gemmel
mesh_terms: D000368:Aged; D001859:Bone Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology / Q000556:secondary*; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology; D000069347:Erlotinib Hydrochloride; D019788:Fluorodeoxyglucose F18 / Q000378:metabolism; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology; D008297:Male; D064847:Multimodal Imaging; D010006:Osteoblasts / Q000000981:diagnostic imaging* / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D049268:Positron-Emission Tomography; D011799:Quinazolines / Q000494:pharmacology / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D011799:Quinazolines; D019788:Fluorodeoxyglucose F18; D000069347:Erlotinib Hydrochloride